Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 04/28 07:53:54 pm
86.471 EUR   +0.58%
07:28p SANOFI SA (NYSE : SNY) reported earnings of $1.42 per share beating ..
04:47p SANOFI : beats 1Q profit forecasts
04:02p SANOFI : and Regeneron receive CHMP positive opinion for rheumatoid ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
07:28p SANOFI SA (NYSE : SNY) reported earnings of $1.42 per share beating Walls Street..
04:47p SANOFI : beats 1Q profit forecasts
04:02p SANOFI : and Regeneron receive CHMP positive opinion for rheumatoid arthritis tr..
10:30a REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
07:45aDJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
07:31a SANOFI : Delivers Robust Q1 2017 Financial Results
07:01a SANOFI : and Regeneron Announce Kevzara® (sarilumab) Biologics License Applicati..
07:01a SANOFI : Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Ap..
04/27 SANOFI : Reports Outline Rabies Vaccines Study Findings from Sanofi Pasteur (G-p..
04/26 SANOFI : US Department of Defense Announces Decision to Give Pharmaceutical Corp..
More news
Sector news : Pharmaceuticals - NEC
05:59pDJBRISTOL MYERS SQUIBB : China Approves Bristol-Myers Dual-Drug Hepatitis C Treatm..
02:37pDJBRISTOL MYERS SQUIBB : China Approves Bristol-Myers Squibb's Dual-Drug Hepatitis..
07:45aDJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27DJASTRAZENECA : Faces Shareholder Uprising Over Changes to Executive Award
04/27DJASTRAZENECA : Profit Drops on Decline in Blockbuster-Drug Revenue -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
10:07a Sanofi 2017 Q1 - Results - Earnings Call Slides
07:31a FDA accepts sarilumab BLA resubmission, action date May 22
07:13a Sanofi Q1 top line up 11%; earnings up 425% on sale of animal heath unit; sha..
05:46a Sanofi reports Q1 results
04/27 Notable earnings before Friday?s open
Advertisement
Financials (€)
Sales 2017 36 417 M
EBIT 2017 9 416 M
Net income 2017 6 661 M
Debt 2017 4 724 M
Yield 2017 3,53%
P/E ratio 2017 16,59
P/E ratio 2018 17,75
EV / Sales 2017 3,18x
EV / Sales 2018 3,04x
Capitalization 111 075 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 83,5 €
Spread / Average Target -2,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias A. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI11.79%120 647
JOHNSON & JOHNSON7.40%335 446
ROCHE HOLDING LTD.10.83%225 921
NOVARTIS AG2.77%203 449
PFIZER INC.4.25%201 641
MERCK & CO., INC.6.30%171 565
More Results